Opportunity had plenty of doors to knock on at ConvergeSouth 2026, held August 27-28 in downtown Winston-Salem’s Innovation ...

Digital healthcare firm Higgs Boson Health, a Durham-based portfolio company of the North Carolina Biotechnology Center, has been acquired by Globus Medical. Higgs Boson Health's technology and staff ...

Cambrex’s inspection approvals follow the company’s $38 million expansion of the High Point facility completed in 2023. The ...

By all accounts, the approach works. QHP has $4.5 billion in assets under management, and its newest fund, the NovaQuest ...

Innatrix Inc., a Durham-based agricultural biotechnology company developing sustainable biological crop protection solutions, ...

We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.

NCBiotech's Military Outreach and Veterans Engagement (MOVE) Boots to Biotech program connects transitioning service members, ...

“Miracle Road” is the quintessential diary of what, how, and especially who made RTP what it is today, with some closing ...

Join Innovate Carolina on September 10 for a seminar discussing NCInnovation's grant program for faculty innovators.

Eight of the top 10 largest pharma companies (based on 2025 revenue) will have operations in North Carolina, including AbbVie, AstraZeneca, Johnson & Johnson, Lilly, Merck, Pfizer, Roche/Genentech and ...

CorestemChemon, a biopharmaceutical company headquartered in South Korea, has begun U.S. operations based in Winston-Salem’s Innovation Quarter. The company’s U.S. subsidiary, CorestemChemon US Inc., ...